CVE-2024-27930

Public Exploit
Sensitive fields access through dropdowns in GLPI

Description

GLPI is a Free Asset and IT Management Software package, Data center management, ITIL Service Desk, licenses tracking and software auditing. An authenticated user can access sensitive fields data from items on which he has read access. This issue has been patched in version 10.0.13.

Category

6.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.30%
Vendor Advisory github.com
Affected: glpi-project glpi
Published at:
Updated at:

References

Link Tags
https://github.com/glpi-project/glpi/security/advisories/GHSA-82vv-j9pr-qmwq vendor advisory
https://github.com/glpi-project/glpi/commit/1942b70b2422fff51822f6eb3af500c94760871e patch
https://borelenzo.github.io/stuff/2024/02/29/glpi-pwned.html exploit
https://github.com/glpi-project/glpi/releases/tag/10.0.13 release notes

Frequently Asked Questions

What is the severity of CVE-2024-27930?
CVE-2024-27930 has been scored as a medium severity vulnerability.
How to fix CVE-2024-27930?
To fix CVE-2024-27930, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-27930 being actively exploited in the wild?
It is possible that CVE-2024-27930 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27930?
CVE-2024-27930 affects glpi-project glpi.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.